Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsStem Cell TransplantationPeripheral Blood Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHematopoietic Stem CellsHistocompatibility TestingImmunocompromised HostStem CellsTreatment OutcomeImmunosuppressive AgentsBone Marrow TransplantationRetrospective StudiesTransplantation ChimeraStem Cell NicheTissue DonorsTransplantationHematopoiesisCell DifferentiationLiver TransplantationAntigens, CD34LeukemiaPancytopeniaAdult Stem CellsMesenchymal Stem Cell TransplantationCell LineageGraft SurvivalCord Blood Stem Cell TransplantationMice, Inbred C57BLHLA AntigensCell TransplantationBone Marrow CellsKidney TransplantationBone MarrowAnemia, AplasticEmbryonic Stem CellsMyeloablative AgonistsFlow CytometryCombined Modality TherapyBusulfanMultiple MyelomaColony-Forming Units AssayFetal BloodRecurrenceMelphalanWhole-Body IrradiationRemission InductionCells, CulturedFollow-Up StudiesCell ProliferationHematopoietic Stem Cell MobilizationHistocompatibilityGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsDisease-Free SurvivalCell CountCyclophosphamideTime FactorsAntineoplastic Combined Chemotherapy ProtocolsStromal CellsSurvival RateSurvival AnalysisTransplantation ImmunologyVidarabineLung TransplantationNeural Stem CellsSalvage TherapyMesenchymal Stromal CellsGraft RejectionLeukemia, Myeloid, AcuteLymphoma, Non-HodgkinBlood Transfusion, AutologousInduced Pluripotent Stem CellsGraft vs Tumor EffectOrgan TransplantationChimerismTransplantation, IsogeneicAntifungal AgentsLymphocyte TransfusionHematologic DiseasesSiblingsMyelodysplastic SyndromesGranulocyte Colony-Stimulating FactorMultipotent Stem CellsHodgkin DiseaseIslets of Langerhans TransplantationImmunosuppressionCytarabineAntilymphocyte SerumSignal TransductionPrecursor Cell Lymphoblastic Leukemia-LymphomaEtoposideT-Lymphocytes